myelodysplastic syndrome

Summary
Definition
A bone marrow cancer that is characterized by under production of white blood cells, red blood cells and platelets.
Super Class
bone marrow cancer
Related Genes
Displaying entries 41 - 50 of 86 in total
Gene ID Gene Symbol Description Source
4684 NCAM1 neural cell adhesion molecule 1
4968 OGG1 8-oxoguanine DNA glycosylase
5048 PAFAH1B1 platelet activating factor acetylhydrolase 1b regulatory subunit 1
5230 PGK1 phosphoglycerate kinase 1
5277 PIGA phosphatidylinositol glycan anchor biosynthesis class A
5290 PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
5291 PIK3CB phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
5293 PIK3CD phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
5294 PIK3CG phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
5305 PIP4K2A phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
Displaying all 3 entries
Gene ID Gene Symbol Description Source
15926 Idh1 isocitrate dehydrogenase 1 (NADP+), soluble
21926 Tnf tumor necrosis factor
22059 Trp53 transformation related protein 53
Displaying all 3 entries
Gene ID Gene Symbol Description Source
24479 Idh1 isocitrate dehydrogenase (NADP(+)) 1
24835 Tnf tumor necrosis factor
24842 Tp53 tumor protein p53
Displaying all 3 entries
Gene ID Gene Symbol Description Source
850871 IDP2 isocitrate dehydrogenase (NADP(+)) IDP2
851493 IDP1 isocitrate dehydrogenase (NADP(+)) IDP1
855723 IDP3 isocitrate dehydrogenase (NADP(+)) IDP3

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024